Showing 1 - 2 results of 2 for search 'Nicholas N Vahanian', query time: 0.01s Refine Results
  1. 1
    Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.

    Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses. by Wenlan Alex Chen, Jinjin Zhang, Katie M Hall, Carol B Martin, Serguei Kisselev, Emily J Dasen, Nicholas N Vahanian, Charles J Link, Brian K Martin

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

    Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma by Ramses Sadek, Mohammed Milhem, Olivier Rixe, David Munn, Christopher M Smith, Yousef Zakharia, Joseph Drabick, Kenneth F Grossmann, Robert R McWilliams, Montaser F Shaheen, Ravindra Kolhe, Rafal Pacholczyk, Lucinda L Tennant, Eugene P Kennedy, Charles J Link Jr, Nicholas N Vahanian, Jiayi Yu, Steven S Shen, Erik L Brincks, Gabriela R Rossi

    Published 2021-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: